07/06/2007 (Agence Europe) - In a press release published on Wednesday 6 June, the European Medicines Agency announced that it had been informed during the evening of 5 June, by the Roche laboratory in Switzerland that certain batches of anti-retroviral Viracept (Nelfinavir) used in the treatment of HIV infections, had been contaminated and that the laboratory had recalled all of these batches from medical use. In a separate press release, Roche indicated that the detailed analysis of...